Cataract Surgeons Gain a New Lens Tool
An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.
By
Kathryn Wighton
March 12, 2026
Clinical Scorecard: Cataract Surgeons Gain a New Lens Tool
At a Glance
Category Detail
Condition Cataract-related vision loss and presbyopia Key Mechanisms Extended depth of focus intraocular lens designed to improve distance and intermediate vision while providing some near vision capability. Target Population Adult patients undergoing cataract surgery, including those with preoperative corneal astigmatism. Care Setting Cataract surgery clinics and ophthalmology practices.
Key Highlights
TECNIS PureSee IOL is FDA-approved for cataract surgery. Maintains contrast sensitivity comparable to aspheric monofocal IOLs. 97% of patients reported no bothersome visual disturbances post-implantation. Improves intermediate visual acuity while maintaining distance visual acuity. A toric version is available for patients with corneal astigmatism. Guideline-Based Recommendations
Diagnosis
Evaluate cataract severity and impact on daily activities. Management
Consider TECNIS PureSee IOL for patients with cataracts and presbyopia. Monitoring & Follow-up
Assess visual outcomes and patient satisfaction post-implantation. Risks
Monitor for potential visual disturbances such as halos or glare. Patient & Prescribing Data
Adults with cataracts and presbyopia, including those with astigmatism.
TECNIS PureSee IOL offers a balance of distance, intermediate, and some near vision capabilities.
Clinical Best Practices
Ensure thorough preoperative assessment of visual needs. Discuss potential outcomes and risks with patients prior to surgery. Utilize the TECNIS PureSee IOL for patients seeking improved intermediate vision. References
